ET Exclusive | Biologics merger with Biocon most value-accretive option: Kiran Mazumdar Shawby Asia Today Team December 7, 2025 0 Biocon will totally combine Biocon Biologics as an entirely owned subsidiary in a transaction valuing the biosimilar enterprise at $5.5 ...